{"id":"cyclo-vcr-pred-dacarb-etop-and-doxo","safety":{"commonSideEffects":[{"rate":"20-50%","effect":"Myelosuppression"},{"rate":"10-30%","effect":"Nausea and vomiting"},{"rate":"10-20%","effect":"Hair loss"},{"rate":"5-15%","effect":"Infection"},{"rate":"5-10%","effect":"Bleeding"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Cyclophosphamide works by attaching an alkyl group to the DNA of cancer cells, which interferes with their ability to replicate and causes cell death. This leads to a reduction in the number of cancer cells in the body. The exact mechanism of action is not fully understood, but it is thought to involve the formation of DNA cross-links and the activation of various cellular pathways that lead to cell death.","oneSentence":"Cyclophosphamide is an alkylating agent that interferes with DNA replication, causing cell death in rapidly dividing cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:08:20.619Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Multiple myeloma"},{"name":"Lymphoma"},{"name":"Leukemia"}]},"trialDetails":[{"nctId":"NCT02684708","phase":"PHASE3","title":"Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Giessen","startDate":"2015-10-01","conditions":"Classical Hodgkin Lymphoma","enrollment":2200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CYC, VCR, PRED, DTIC, ETO, DOXO"],"phase":"phase_3","status":"active","brandName":"cyclo, vcr, pred, dacarb,etop and doxo","genericName":"cyclo, vcr, pred, dacarb,etop and doxo","companyName":"University of Giessen","companyId":"university-of-giessen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cyclophosphamide is an alkylating agent that interferes with DNA replication, causing cell death in rapidly dividing cells. Used for Multiple myeloma, Lymphoma, Leukemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}